Last reviewed · How we verify

NCT04030182

Vitamin D Deficit in Women With Uterine Fibroids

Completed Last updated 8 November 2021
What this trial tests

trial testing Level of Vitamin D in Leiomyoma in 127 participants. Completed in 9 October 2021.

Timeline
1 December 2019
Primary endpoint
9 October 2021
9 October 2021

Quick facts

Lead sponsorInstituto Mexicano del Seguro Social
StatusCompleted
Study typeOBSERVATIONAL
Enrollment127
Start date1 December 2019
Primary completion9 October 2021
Estimated completion9 October 2021
Sites2 locations across Mexico

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Mexicano del Seguro Social — full company profile →

Who can join

Adults 18 to 50, female only, with Leiomyoma or Vitamin D Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determinate the level of vitamin D in blood, and evaluate the prevalence of deficit and insufficiency among patients with diagnosis of uterine fibroids

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Vitamin D, immune microenvironment, and cervical lesions: mechanisms and therapeutic strategies from polyps to carcinoma.
    He Z, Du C. · · 2025 · PMID 41245397 · DOI 10.3389/fnut.2025.1688910

Verify or expand the search:

Other recruiting trials for Leiomyoma

Currently open trials in the same condition.

Other Instituto Mexicano del Seguro Social trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04030182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing